Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1985 | 5079 | 40.6 | 82% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
252 | 41951 | PHEOCHROMOCYTOMA//NEUROBLASTOMA//ALDOSTERONE |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
2008 | 2324 | ALDOSTERONE//EPLERENONE//SPIRONOLACTONE |
2137 | 2275 | 11 BETA HYDROXYSTEROID DEHYDROGENASE//11 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1//11 BETA HSD1 |
18558 | 480 | HIGH BLOOD P SURE UNIT//ADRENOCORTICOTROPHIC HORMONE//GLUCOCORTICOID INDUCED HYPERTENSION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | 11 BETA HYDROXYSTEROID DEHYDROGENASE | Author keyword | 470 | 74% | 7% | 344 |
2 | ALDOSTERONE | Author keyword | 283 | 26% | 19% | 941 |
3 | EPLERENONE | Author keyword | 184 | 67% | 3% | 164 |
4 | 11 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 | Author keyword | 183 | 84% | 2% | 98 |
5 | MINERALOCORTICOID RECEPTOR | Author keyword | 150 | 39% | 6% | 304 |
6 | SPIRONOLACTONE | Author keyword | 121 | 36% | 5% | 274 |
7 | 11 BETA HSD1 | Author keyword | 119 | 75% | 2% | 85 |
8 | MOL HYPERTENS | Address | 63 | 81% | 1% | 38 |
9 | HIGH BLOOD P SURE UNIT | Address | 47 | 88% | 0% | 22 |
10 | 11 BETA HSD2 | Author keyword | 42 | 62% | 1% | 43 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 11 BETA HYDROXYSTEROID DEHYDROGENASE | 470 | 74% | 7% | 344 | Search 11+BETA+HYDROXYSTEROID+DEHYDROGENASE | Search 11+BETA+HYDROXYSTEROID+DEHYDROGENASE |
2 | ALDOSTERONE | 283 | 26% | 19% | 941 | Search ALDOSTERONE | Search ALDOSTERONE |
3 | EPLERENONE | 184 | 67% | 3% | 164 | Search EPLERENONE | Search EPLERENONE |
4 | 11 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 | 183 | 84% | 2% | 98 | Search 11+BETA+HYDROXYSTEROID+DEHYDROGENASE+TYPE+1 | Search 11+BETA+HYDROXYSTEROID+DEHYDROGENASE+TYPE+1 |
5 | MINERALOCORTICOID RECEPTOR | 150 | 39% | 6% | 304 | Search MINERALOCORTICOID+RECEPTOR | Search MINERALOCORTICOID+RECEPTOR |
6 | SPIRONOLACTONE | 121 | 36% | 5% | 274 | Search SPIRONOLACTONE | Search SPIRONOLACTONE |
7 | 11 BETA HSD1 | 119 | 75% | 2% | 85 | Search 11+BETA+HSD1 | Search 11+BETA+HSD1 |
8 | 11 BETA HSD2 | 42 | 62% | 1% | 43 | Search 11+BETA+HSD2 | Search 11+BETA+HSD2 |
9 | GLUCOCORTICOID METABOLISM | 40 | 77% | 1% | 27 | Search GLUCOCORTICOID+METABOLISM | Search GLUCOCORTICOID+METABOLISM |
10 | MINERALOCORTICOID | 33 | 32% | 2% | 87 | Search MINERALOCORTICOID | Search MINERALOCORTICOID |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | APPARENT MINERALOCORTICOID EXCESS | 410 | 69% | 7% | 354 |
2 | CORTICOSTEROID 11 BETA DEHYDROGENASE | 349 | 91% | 3% | 144 |
3 | EPLERENONE | 239 | 64% | 5% | 236 |
4 | SPIRONOLACTONE | 219 | 37% | 9% | 470 |
5 | 11 BETA HYDROXYSTEROID DEHYDROGENASE TYPE 1 | 188 | 41% | 7% | 353 |
6 | CORTISOL METABOLISM | 185 | 73% | 3% | 143 |
7 | HEXOSE 6 PHOSPHATE DEHYDROGENASE | 160 | 75% | 2% | 115 |
8 | MINERALOCORTICOID RECEPTOR | 159 | 34% | 8% | 390 |
9 | BETA HYDROXYSTEROID DEHYDROGENASE | 154 | 54% | 4% | 199 |
10 | 11 BETA HYDROXYSTEROID DEHYDROGENASE | 153 | 33% | 8% | 383 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of Mineralocorticoid Receptor Antagonists in Cardiovascular Disease | 2015 | 4 | 84 | 74% |
11 beta-HYDROXYSTEROID DEHYDROGENASES: INTRACELLULAR GATE-KEEPERS OF TISSUE GLUCOCORTICOID ACTION | 2013 | 47 | 735 | 67% |
11 beta-hydroxysteroid dehydrogenase type 1: A tissue-specific regulator of glucocorticoid response | 2004 | 518 | 358 | 77% |
Mineralocorticoid Receptor Activation and Mineralocorticoid Receptor Antagonist Treatment in Cardiac and Renal Diseases | 2015 | 2 | 103 | 83% |
Mineralocorticoid receptors in the heart: lessons from cell-selective transgenic animals | 2015 | 2 | 85 | 73% |
Aldosterone: effects on the kidney and cardiovascular system | 2010 | 98 | 137 | 79% |
Vascular Actions of Aldosterone | 2013 | 23 | 83 | 88% |
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension | 2009 | 150 | 45 | 64% |
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders? | 2013 | 24 | 103 | 75% |
Aldosterone synthase inhibitors in cardiovascular and renal diseases | 2014 | 9 | 38 | 82% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL HYPERTENS | 63 | 81% | 0.7% | 38 |
2 | HIGH BLOOD P SURE UNIT | 47 | 88% | 0.4% | 22 |
3 | MOL SYST TOXICOL | 21 | 48% | 0.6% | 32 |
4 | U478 | 9 | 25% | 0.6% | 31 |
5 | MED CHEM CLIN PHARM | 7 | 50% | 0.2% | 10 |
6 | REG ENDOCRINE UNIT | 7 | 41% | 0.3% | 13 |
7 | DEV ENDOCRINE SIGNALLING | 4 | 42% | 0.2% | 8 |
8 | JULIUS BERNSTEIN PHYSIOL | 4 | 18% | 0.4% | 21 |
9 | QUEEN ELIZABETH HOSP MED | 4 | 56% | 0.1% | 5 |
10 | ASSAY DEV SCREENING | 3 | 39% | 0.1% | 7 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000019543 | GLUCOCORTICOID RECEPTOR//GLUCOCORTICOID RESISTANCE//TRANSREPRESSION |
2 | 0.0000015920 | GLYCYRRHIZIN//LICORICE//GLABRIDIN |
3 | 0.0000013110 | TORASEMIDE//HYPERKALEMIA//FUROSEMIDE |
4 | 0.0000011561 | KCC2//ENAC//EPITHELIAL SODIUM CHANNEL |
5 | 0.0000011226 | CONGENITAL ADRENAL HYPERPLASIA//21 HYDROXYLASE DEFICIENCY//CYP21A2 |
6 | 0.0000010111 | DOPING CONTROL//EPITESTOSTERONE//DOPING ANALYSIS |
7 | 0.0000009988 | GITELMANS SYNDROME//GITELMAN SYNDROME//BARTTER SYNDROME |
8 | 0.0000009714 | CORTISOL AWAKENING RESPONSE//SALIVARY CORTISOL//HAIR CORTISOL |
9 | 0.0000009479 | ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM |
10 | 0.0000009303 | PHEOCHROMOCYTOMA//NEUROBLASTOMA//PRIMARY ALDOSTERONISM |